Amedeo Smart

Free Medical Literature Service

 

Amedeo

Alzheimer's Disease
  Free Subscription

Articles published in
Exp Neurol
    July 2024
  1. ZHAO Y, He C, Hu S, Ni H, et al
    Anti-oxidative stress and cognitive improvement of a semi-synthetic isoorientin-based GSK-3beta inhibitor in rat pheochromocytoma cell PC12 and scopolamine-induced AD model mice via AKT/GSK-3beta/Nrf2 pathway.
    Exp Neurol. 2024 Jul 10:114881. doi: 10.1016/j.expneurol.2024.114881.
    >> Share

  2. LI CL, Zhou GF, Xie XY, Wang L, et al
    STAU1 exhibits a dual function by promoting amyloidogenesis and tau phosphorylation in cultured cells.
    Exp Neurol. 2024;377:114805.
    >> Share

    May 2024
  3. HUANG XY, Xue LL, Ma RF, Shi JS, et al
    Inhibition of CXCR4: A perspective on miracle fruit seed for Alzheimer's disease treatment.
    Exp Neurol. 2024 May 29:114841. doi: 10.1016/j.expneurol.2024.114841.
    >> Share

  4. EL-ARABY RE, Wasif K, Johnson R, Tu Q, et al
    Establishment of a novel cellular model for Alzheimer's disease in vitro studies.
    Exp Neurol. 2024 May 22:114820. doi: 10.1016/j.expneurol.2024.114820.
    >> Share

  5. ZHANG Y, Mu BR, Ran Z, Zhu T, et al
    Pericytes in Alzheimer's disease: Key players and therapeutic targets.
    Exp Neurol. 2024 May 20:114825. doi: 10.1016/j.expneurol.2024.114825.
    >> Share

  6. BARATI N, Shojaeian A, Ramezani M, Kalhori F, et al
    Investigating the effect of parasites (toxoplasma gondii RH strain, Leishmania major (MRHO/IR/75/ER), and hydatid cyst) antigens on Alzheimer's disease: An in vivo evaluation.
    Exp Neurol. 2024;377:114813.
    >> Share

    March 2024
  7. ZHUGE F, Zheng L, Pan Y, Ni L, et al
    DPP-4 inhibition by linagliptin ameliorates age-related mild cognitive impairment by regulating microglia polarization in mice.
    Exp Neurol. 2024;373:114689.
    >> Share

  8. ZUO Y, Liu HT, Lin LB, Yue RZ, et al
    A new metal ion chelator attenuates human tau accumulation-induced neurodegeneration and memory deficits in mice.
    Exp Neurol. 2024;373:114657.
    >> Share

    February 2024
  9. ESHANI M, Anupam R, Raj SA, Ashish J, et al
    To evaluate the effect of endothelin receptor agonist IRL-1620 alone and in combination with donepezil in modulating neurodegeneration elicited by amyloid-beta in rats.
    Exp Neurol. 2024 Feb 9:114720. doi: 10.1016/j.expneurol.2024.114720.
    >> Share

    January 2024
  10. XU M, Li J, Xia L, Du Y, et al
    PCSK6 exacerbates Alzheimer's disease pathogenesis by promoting MT5-MMP maturation.
    Exp Neurol. 2024 Jan 10:114688. doi: 10.1016/j.expneurol.2024.114688.
    >> Share

  11. YUBOLPHAN R, Pratchayasakul W, Koonrungsesomboon N, Chattipakorn N, et al
    Potential links between platelets and amyloid-beta in the pathogenesis of Alzheimer's disease: Evidence from in vitro, in vivo, and clinical studies.
    Exp Neurol. 2024 Jan 9:114683. doi: 10.1016/j.expneurol.2024.114683.
    >> Share

  12. DEMBY T, Gross PS, Mandelblatt J, Huang JK, et al
    The chemotherapeutic agent doxorubicin induces brain senescence, with modulation by APOE genotype.
    Exp Neurol. 2024;371:114609.
    >> Share

    September 2023
  13. HOSSEININIA M, Rostami F, Delphi L, Ghasemzadeh Z, et al
    Memory impairment was ameliorated by corticolimbic microinjections of arachidonylcyclopropylamide (ACPA) and miRNA-regulated lentiviral particles in a streptozotocin-induced Alzheimer's rat model.
    Exp Neurol. 2023 Sep 30:114560. doi: 10.1016/j.expneurol.2023.114560.
    >> Share

  14. UPADHYAY P, Gupta S
    Dual mode of Triphala in the reversal of cognition through gut restoration in antibiotic mediated prolonged dysbiosis condition in 5XFAD mice.
    Exp Neurol. 2023;367:114473.
    >> Share

    August 2023
  15. TIAN S, Ye T, Cheng X
    The behavioral, pathological and therapeutic features of the triple transgenic Alzheimer's disease (3 x Tg-AD) mouse model strain.
    Exp Neurol. 2023 Aug 17:114505. doi: 10.1016/j.expneurol.2023.114505.
    >> Share

  16. HOSSAIN SR, Karem H, Jafari Z, Kolb BE, et al
    Early tactile stimulation influences the development of Alzheimer's disease in gestationally stressed APP (NL-G-F) adult offspring (NL-G-F/NL-G-F) mice.
    Exp Neurol. 2023 Aug 1:114498. doi: 10.1016/j.expneurol.2023.114498.
    >> Share

    June 2023
  17. DU K, Dou Y, Chen K, Zhao Y, et al
    Activation of TRPV4 induces intraneuronal tau hyperphosphorylation via cholesterol accumulation.
    Exp Neurol. 2023;364:114392.
    >> Share

    May 2023
  18. GHASEMI A, Qaffaripour Z, Tourani M, Saleki K, et al
    The relationship between long non-coding RNAs and Wnt/beta-catenin signaling pathway in the pathogenesis of Alzheimer's disease.
    Exp Neurol. 2023 May 16:114434. doi: 10.1016/j.expneurol.2023.114434.
    >> Share

  19. WANG YY, Zhou YN, Jiang L, Wang S, et al
    Long-term voluntary exercise inhibited AGE/RAGE and microglial activation and reduced the loss of dendritic spines in the hippocampi of APP/PS1 transgenic mice.
    Exp Neurol. 2023;363:114371.
    >> Share

    April 2023
  20. JAFARI Z, Afrashteh N, Kolb BE, Mohajerani MH, et al
    Hearing loss and impaired short-term memory in an Alzheimer's disease mouse model of amyloid-beta pathology.
    Exp Neurol. 2023 Apr 17:114413. doi: 10.1016/j.expneurol.2023.114413.
    >> Share

  21. YANG YY, Ren YT, Jia MY, Bai CY, et al
    The human islet amyloid polypeptide reduces hippocampal tauopathy and behavioral impairments in P301S mice without inducing neurotoxicity or seeding amyloid aggregation.
    Exp Neurol. 2023;362:114346.
    >> Share

  22. WU SL, Yu B, Cheng YJ, Ren SY, et al
    Brain region-specific myelinogenesis is not directly linked to amyloid-beta in APP/PS1 transgenic mice.
    Exp Neurol. 2023;362:114344.
    >> Share

  23. LI L, Miao J, Jiang Y, Dai CL, et al
    Passive immunization inhibits tau phosphorylation and improves recognition learning and memory in 3xTg-AD mice.
    Exp Neurol. 2023;362:114337.
    >> Share

    March 2023
  24. MEI Y, Li Y, Cheng YX, Gao L, et al
    The effect of gastric bypass surgery on cognitive function of Alzheimer's disease and the role of GLP1-SGLT1 pathway.
    Exp Neurol. 2023 Mar 7:114377. doi: 10.1016/j.expneurol.2023.114377.
    >> Share

  25. KNOX KM, Beckman M, Smith CL, Jayadev S, et al
    Chronic seizures induce sex-specific cognitive deficits with loss of presenilin 2 function.
    Exp Neurol. 2023;361:114321.
    >> Share

  26. WANG C, Chang Y, Zhu J, Wu Y, et al
    AdipoRon mitigates tau pathology and restores mitochondrial dynamics via AMPK-related pathway in a mouse model of Alzheimer's disease.
    Exp Neurol. 2023;363:114355.
    >> Share

    January 2023
  27. LV J, Duan Y, Wang X, Wu H, et al
    Alpha7 nicotinic acetylcholine receptor agonist PHA-543613 improves memory deficits in presenilin 1 and presenilin 2 conditional double knockout mice.
    Exp Neurol. 2023;359:114271.
    >> Share

  28. KUMARI E, Xu A, Chen R, Yan Y, et al
    FSTL1-knockdown improves neural oscillation via decreasing neuronal-inflammation regulating apoptosis in Abeta(1-42) induced AD model mice.
    Exp Neurol. 2023;359:114231.
    >> Share

    November 2022
  29. BLANTON H, Reddy PH, Benamar K
    Chronic pain in Alzheimer's disease: Endocannabinoid system.
    Exp Neurol. 2022 Nov 28:114287. doi: 10.1016/j.expneurol.2022.114287.
    >> Share

    August 2022
  30. GOMES P, Tzouanou F, Skolariki K, Iakovou AV, et al
    Extracellular vesicles and Alzheimer's disease in the novel era of Precision Medicine: Implications for disease progression, diagnosis and treatment.
    Exp Neurol. 2022 Aug 8:114183. doi: 10.1016/j.expneurol.2022.114183.
    >> Share

    June 2022
  31. HUSSEIN A, Tielemans A, Baxter MG, Benson DL, et al
    Cognitive deficits and altered cholinergic innervation in young adult male mice carrying a Parkinson's disease Lrrk2(G2019S) knockin mutation.
    Exp Neurol. 2022 Jun 19:114145. doi: 10.1016/j.expneurol.2022.114145.
    >> Share

    December 2021
  32. SPOLETI E, Krashia P, La Barbera L, Nobili A, et al
    Early derailment of firing properties in CA1 pyramidal cells of the ventral hippocampus in an Alzheimer's disease mouse model.
    Exp Neurol. 2021 Dec 30:113969. doi: 10.1016/j.expneurol.2021.113969.
    >> Share

    October 2021
  33. PENG YG, Cai PJ, Hu JH, Jiang JX, et al
    Altered corticostriatal synchronization associated with compulsive-like behavior in APP/PS1 mice.
    Exp Neurol. 2021;344:113805.
    >> Share

    September 2021
  34. WANG J, Liu B, Xu Y, Luan H, et al
    Thioperamide attenuates neuroinflammation and cognitive impairments in Alzheimer's disease via inhibiting gliosis.
    Exp Neurol. 2021;347:113870.
    >> Share

    August 2021
  35. LI ZY, Chen LH, Zhao XY, Chen H, et al
    Clemastine attenuates AD-like pathology in an AD model mouse via enhancing mTOR-mediated autophagy.
    Exp Neurol. 2021;342:113742.
    >> Share

    May 2021
  36. ISLA AG, Balleza-Tapia H, Fisahn A
    Efficacy of preclinical pharmacological interventions against alterations of neuronal network oscillations in Alzheimer's disease: A systematic review.
    Exp Neurol. 2021 May 14:113743. doi: 10.1016/j.expneurol.2021.113743.
    >> Share

  37. ANNADURAI N, De Sanctis JB, Hajduch M, Das V, et al
    Tau secretion and propagation: Perspectives for potential preventive interventions in Alzheimer's disease and other tauopathies.
    Exp Neurol. 2021 May 11:113756. doi: 10.1016/j.expneurol.2021.113756.
    >> Share

    March 2021
  38. NEVES AF, Camargo C, Premer C, Hare JM, et al
    Intravenous administration of mesenchymal stem cells reduces Tau phosphorylation and inflammation in the 3xTg-AD mouse model of Alzheimer's disease.
    Exp Neurol. 2021 Mar 20:113706. doi: 10.1016/j.expneurol.2021.113706.
    >> Share

  39. MANSOUR HM, Fawzy HM, El-Khatib AS, Khattab MM, et al
    Lapatinib ditosylate rescues memory impairment in D-galactose/ovariectomized rats: Potential repositioning of an anti-cancer drug for the treatment of Alzheimer's disease.
    Exp Neurol. 2021 Mar 13:113697. doi: 10.1016/j.expneurol.2021.113697.
    >> Share

    January 2021
  40. NAKANISHI K, Sakakima H, Norimatsu K, Otsuka S, et al
    Effect of low-intensity motor balance and coordination exercise on cognitive functions, hippocampal Abeta deposition, neuronal loss, neuroinflammation, and oxidative stress in a mouse model of Alzheimer's disease.
    Exp Neurol. 2021;337:113590.
    >> Share

  41. MCKNIGHT I, Hart C, Park IH, Shim JW, et al
    Genes causing congenital hydrocephalus: Their chromosomal characteristics of telomere proximity and DNA compositions.
    Exp Neurol. 2021;335:113523.
    >> Share

    December 2020
  42. TANAKA T, Hirai S, Hosokawa M, Saito T, et al
    Early-life stress induces the development of Alzheimer's disease pathology via angiopathy.
    Exp Neurol. 2020 Dec 9:113552. doi: 10.1016/j.expneurol.2020.113552.
    >> Share

  43. CHEN HC, Cao JX, Cai YT, Du HL, et al
    Interaction of human IAPP and Abeta1-42 aggravated the AD-related pathology and impaired the cognition in mice.
    Exp Neurol. 2020;334:113490.
    >> Share

    May 2020
  44. CHEN C, Xu D, Zhang ZH, Jia SZ, et al
    Cognitive improvement and synaptic deficit attenuation by a multifunctional carbazole-based cyanine in AD mice model through regulation of Ca(2+)/CaMKII/CREB signaling pathway.
    Exp Neurol. 2020;327:113210.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016